Tirzepatide

For most people, the word diet sounds like a four-letter word. Avoiding carbs, eating less, and not thinking of food is harder than it sounds. The recent diet medications, like Semaglutide and Tirzepatide , can make this process much easier and weight loss results more achievable.

The recent FDA approval of Tirzepatide (brand named Mounjaro for diabetes and Zepbound for weight loss) has helped make Tirzepatide a common word all over the world. With recent studies proving that in randomly controlled studies participants were able to lose over 20% of their body weight while using Tirzepatide , it is no mistake that Tirzepatide is becoming the go to medication when thinking of dieting and losing weight.

What sets Tirzepatide apart from its predecessor, Semaglutide, is that it is a combination of two peptides instead of the one found in Semaglutide. Why are two peptides better? These two peptides act similar but have slightly different characteristics that allow users of Tirzepatide to have a different experience than those who have tried the single peptide weight loss drug, Semaglutide.

The Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP) are the two peptides in Tirzepatide. Each plays a role in helping the pancreas secrete insulin more efficiently, each helps to slow down the stomachs digestion and emptying of food, which helps you get full faster and stay fuller longer, and each helps you to have a reduced appetite. The benefit of having two peptides is that the two work on different receptor sites allowing the benefits to be felt for longer periods of time with less side effects.

Studies are showing that the use of these medications can also improve liver function, kidney function, improve cardiovascular health, reduce inflammation, curb desire for alcohol and many more health benefits.